BiotechTube
Home/Curasight/Ulrich Krasilnikoff
UK

Ulrich Krasilnikoff

Chief Executive Officer & Chief Financial Officer

Curasight

Therapeutic Areas

Oncology

Curasight Pipeline

DrugIndicationPhase
uTREAT® (177Lu-CUR-N86)Glioblastoma (Recurrent)Phase 1/2a
uTREAT®Prostate CancerPreclinical
uTRACE® (68Ga-CUR-N86)Diagnostic Imaging (Multiple Solid Tumors)Phase 2

Leadership Team at Curasight

AK
Andreas Kjær
Chief Scientific Officer, Co-founder
HD
Hanne Damgaard Jensen
Chief Operating Officer
SF
Søren Fabricius
Chief Development Officer
KD
Kirsten Drejer
Chairperson of the Board
MR
Marcel Reichen
Board Member
DC
Dr. Colin Hayward
Board Member
View full Curasight profile